Poster 2022 4

Prognostic value of baseline FDG-PET/CT radiomics for prediction of bone marrow minimal residual disease status in the LyMa-101 Trial
C. Morvant, C. Bailly, T. Carlier, G. Frecon, F. Kraeber-Bodéré, S. Le Gouill, E. Macintyre, C. Bodet-Milin,
J. Nucl. Med. Meeting Abstracts, SNM congress 2022, Vancouver, Canada